Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis

被引:21
|
作者
Sugimoto, Eiki [1 ]
Matsuda, Hiroki [1 ]
Shibata, Sayaka [1 ]
Mizuno, Yuka [1 ]
Koyama, Asumi [1 ]
Li, Lixin [1 ]
Taira, Haruka [1 ]
Ito, Yukiko [1 ]
Awaji, Kentaro [1 ]
Yamashita, Takashi [1 ]
Sato, Shinichi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan
关键词
biologics; conventional systemic agents; PLR; SII; treatment response; NEUTROPHIL-LYMPHOCYTE RATIO; CARDIOVASCULAR-DISEASES; ADIPONECTIN LEVELS; PLATELET; PATHOGENESIS;
D O I
10.3390/jcm12083046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic inflammation plays a central role in the pathophysiology of psoriasis. This study examined accessible systemic inflammatory markers in patients with psoriasis vulgaris and psoriatic arthritis. We aimed to evaluate their association with psoriasis severity, the presence of arthritis, and drug continuation rates. The findings revealed that neutrophil, monocyte, and platelet count, neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, systemic inflammation response index, systemic immune/inflammation index (SII), and CRP were positively correlated with Psoriasis Area and Severity Index scores. Patients presenting with higher platelet/lymphocyte ratio (PLR) or CRP values were more likely to be diagnosed with psoriatic arthritis than with psoriasis vulgaris in the multivariate regression analysis. Importantly, patients with higher pretreatment neutrophil or platelet count, PLR, and SII were associated with lower treatment continuation rates of conventional systemic agents. Higher pretreatment scores of systemic inflammatory markers did not affect treatment retention rates of biologics. These findings suggest that several accessible systemic inflammatory markers may effectively assess underlying systemic inflammation and may provide an indication for a therapeutic approach in patients with psoriasis vulgaris and psoriatic arthritis.
引用
收藏
页数:14
相关论文
共 16 条
  • [1] Effect of Biological Therapy on Systemic Inflammatory Markers Among Patients with Chronic Plaque Psoriasis
    Kulakli, Sevgi
    Oguz, Isil Deniz
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2023, 61 (03): : 154 - 160
  • [2] Psoriasis/Psoriatic Arthritis Patients' Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations
    Krantz, Asa
    Carrero, Juan Jesus
    Yang, Yuanhang
    Schalin, Lovisa
    Lysell, Josefin
    Mazhar, Faizan
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [3] Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
    Mekinian, Arsene
    Dervin, Guillaume
    Lapidus, Nathanael
    Kahn, Jean-Emmanuel
    Terriou, Louis
    Liozon, Eric
    Grignano, Eric
    Piette, Jean-Charles
    Rauzy, Odile Beyne
    Grobost, Vincent
    Godmer, Pascal
    Gillard, Jerome
    Rossignol, Julien
    Launay, David
    Aouba, Achille
    Cardon, Thierry
    Bouillet, Laurence
    Broner, Jonathan
    Vinit, Julien
    Ades, Lionel
    Carrat, Fabrice
    Salvado, Clementine
    Toussirot, Eric
    Versini, Mathilde
    Costedoat-Chalumeau, Nathalie
    Fraison, Jean Baptiste
    Guilpain, Philippe
    Fenaux, Pierre
    Fain, Olivier
    AUTOIMMUNITY REVIEWS, 2017, 16 (09) : 903 - 910
  • [4] Effectiveness, quality of life, and safety of secukinumab versus conventional systemic therapy in patients with erythrodermic psoriasis: a comparative study
    Zhou, Ying
    Chen, Weiquan
    Fang, Linglu
    Qiu, Fang
    Wu, Jiayuan
    Li, Jing
    FRONTIERS IN MEDICINE, 2024, 11
  • [5] Real-world systemic treatment of patients with psoriasis: A retrospective study based on German claims data
    Heidbrede, Tanja
    Mevius, Antje
    Kessel, Sebastian
    Wilke, Thomas
    Maywald, Ulf
    Thiem, Alexander
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 (06): : 621 - 621
  • [6] Treatment Patterns and Health Care Costs for Patients With Psoriatic Arthritis on Biologic Therapy: A Retrospective Cohort Study
    Zhu, Baojin
    Edson-Heredia, Emily
    Gatz, Jennifer L.
    Guo, Jiaying
    Shuler, Catherine L.
    CLINICAL THERAPEUTICS, 2013, 35 (09) : 1376 - 1385
  • [7] Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study
    Johan Dalén
    Amy Puenpatom
    Karin Luttropp
    Axel Svedbom
    Christopher M. Black
    Advances in Therapy, 2022, 39 : 244 - 255
  • [8] Comparison of Different Systemic Inflammatory Markers in Predicting Clinical Outcomes with Syntax Score in Patients with Non-ST Segment Elevation Myocardial Infarction: A Retrospective Study
    Li, Hong
    Meng, Shuai
    Chen, Weiguang
    Lei, Xuan
    Kong, Xiangyun
    Zhu, Huagang
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 2595 - 2607
  • [9] Association between systemic inflammatory response index and bone turnover markers in Chinese patients with osteoporotic fractures: a retrospective cross-sectional study
    Zhou, Peng
    Lu, Ke
    Li, Chong
    Xu, Min-zhe
    Ye, Yao-wei
    Shan, Hui-qiang
    Yin, Yi
    FRONTIERS IN MEDICINE, 2024, 11
  • [10] Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study
    Granel, J.
    Ravalet, A.
    Daghistani, A.
    Clet, J.
    Richer, O.
    Bailhache, M.
    Pillet, P.
    ARP RHEUMATOLOGY, 2024, 3 (04): : 288 - 294